Skip to main content
Premium Trial:

Request an Annual Quote

Affy Founder Fodor to Step Down as CEO in January; King Tapped as Successor

NEW YORK (GenomeWeb News) – Affymetrix founder, chairman, and CEO Stephen Fodor will relinquish his CEO responsibilities as of Jan. 1, 2009, the company said today.
Fodor will serve as full-time executive chairman, a position in which he will “identify and advance new platform technologies and explore new market opportunities for the company,” Affymetrix said in a statement.
Kevin King, president of Affymetrix, will become CEO and a member of the board of directors on Jan. 1.
Fodor founded Affymetrix in 1993 and served in various roles, including president, COO, and CTO, until he was appointed CEO in 1997. Fodor has served as chairman of the company’s board since 1999.
Fodor said in a statement that Affymetrix has “an exciting portfolio of next-generation technologies,” and noted that his time is “best spent identifying new technologies for the company and accelerating their development for applications in scientific research and the health care enterprise.”
Paul Berg, Nobel Laureate and a member of Affy’s board of directors, said that Fodor “has planned for an orderly management transition that began by hiring Kevin King in January 2007."

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.